Home | Coverage | Agents | Pulse | LogIn |
| Darwin Score | +11 |
| Ticker | NOVO-B |
| Latest Price | 451.30 DKK as of close on 04-Jul-2025 |
| 3 Month price range | 390.00 to 519.80 DKK |
| Market Capitalisation | 1915.76Bn DKK |
| Country | Denmark |
| Region | Europe |
| Economic Sector | Health Care |
| Business Sector | Pharmaceuticals, Biotechnology & Life Sciences |
| Industry | Biotechnology |
| Sub-Industry | Biotechnology |
| Description | Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally. It operates in two segments, Diabetes and Obesity Care, and Rare Disease. The Diabetes and Obesity care segment provides products for diabetes, obesity, cardiovascular, and other emerging therapy areas. The Rare Disease segment offers products in the areas of rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company also provides insulin pens, growth hormone pens, and injection needles. In addition, it offers smart solutions for diabetes treatment, such as smart insulin pens and Dose Check, an insulin dose guidance application. The company has a collaboration agreement with UNICEF to tackle childhood obesity; and with Valo Health, Inc. to discover and develop novel drug programmes for cardiometabolic space. Novo Nordisk A/S was founded in 1923 and is headquartered in Bagsvaerd, Denmark. See More ... |
| Company URL | https://www.novonordisk.com |
| See Darwins Full Analysis for Novo Nordisk A/S |
Tell Me About (TMA) is Darwins structured scoring system for assets. Here are the scores from the key TMA sections for Novo Nordisk A/S. Further information and full detail is available when you login.
| TMA Part | Focus of Analysis | TMA Score |
|---|---|---|
| Price | Analysis of performance, trend, RSI, OBV and moving averages | +4 |
| Sentiment | News and Candle Patterns. | 0 |
| Fundamentals | Analyst Ratings, Valuation and Dividend analysis. | +4 |
| Flow | Institutional, Fund and Insider buying and selling. | 0 |
| Models | Forecast models. | +3 |
There are 4 live alerts for Novo Nordisk A/S. All the alerts are positive.
There are 2 peers of Novo Nordisk A/S.
| Asset Name | Industry Group | Perf(20d)% | Asset Score |
|---|---|---|---|
| Genmab A/S (GMAB) | Biotechnology | -7.9 | -4 |
| Zealand Pharma A/S (ZEAL) | Biotechnology | -21.0 | +1 |
To see complete information on Novo Nordisk A/S or any other assets please login.
If you do not already have an account you can register for a free trial of our service. This will let you explore all the analytical information we have on price, fundamantals, flow, sentiments & models for all the stocks under coverage. You will then be able to compare asset scores and perform a wide range of multi asset analysis such as Market Cycles and Relative Scores.
Follow Us | |
©2025 Darwin Knows - All Rights Reserved | |